Evaluation of Variants and the Effect of Vaccine on Mortality in Pregnant and Postpartum Women Infected with COVID-19
Objective: Due to the anatomical, physiological, and immunological changes associated with pregnancy, pregnant women are a population at risk of coronavirus disease-2019 (COVID-19) disease-related morbidity and mortality. There aren’t enough studies on the conditions of pregnant and puerperal women...
Gespeichert in:
Veröffentlicht in: | Turk Yogun bakim Dernegi Dergisi 2023-03, Vol.21 (1), p.48-54 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Objective: Due to the anatomical, physiological, and immunological changes associated
with pregnancy, pregnant women are a population at risk of coronavirus disease-2019 (COVID-19)
disease-related morbidity and mortality. There aren’t enough studies on the conditions of pregnant
and puerperal women who are being followed up in intensive care. The goal of this study was to
determine if there was a link between variant status, vaccination status, and mortality in pregnant
and puerperal women who were monitored in the intensive care unit during the transition from
the alpha to the delta variation.
Materials and Methods: The study was designed as a 6-month prospective observational study that
occurred between August 1, 2021, and February 1, 2022. Age, present comorbidities, vaccination
status, gravida, parity, gestational age (for pregnant women), variant status, birth style (cesarean
section or normal delivery), and COVID-19 medical therapies in the critical care unit were all
recorded.
Results: During the observation period, forty patients were enrolled in the study. The patients
average age was 30.9±5.2. The pregnant patients’ median gestational week was 32 weeks and 2
days. While 30 of the patients had no concomitant conditions, two had gestational diabetes, four
had hypothyroidism, three had chronic hypertension, and one had Wilson’s disease. In 37.5% of
the patients, intubation was required. During the follow-up in intensive care, ten individuals died.
The patients in the intensive care unit spent an average of 12.1±11.8 days there. While 7 (19.4%)
of the 36 patients with alpha variants died, 3 (75%) of the 4 patients with delta variants died, a
statistically significant difference (p=0.042).
Conclusion: In the pregnant population admitted to the intensive care unit, the delta variant was
associated with a greater mortality rate. In our research, we discovered that the vaccination rate
among pregnant women admitted to the intensive care unit was quite low. |
---|---|
ISSN: | 2602-2974 2146-6416 2602-2974 2147-267X |
DOI: | 10.4274/tybd.galenos.2022.56823 |